Ars Wealth Advisors Group, LLC Cor Medix Inc. Transaction History

Ars Wealth Advisors Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$3.22 - $4.61 $3,220 - $4,610	-1,000 Reduced 8.33%	11,000 $45,000
Q4 2022 Feb 13, 2023	BUY	$2.81 - $4.45 $2,810 - $4,450	1,000 Added 9.09%	12,000 $50,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $31,020 - $82,720	11,000 New	11,000 $70,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.